Loxo Oncology(LOXO)

琳子的日复一日2018-05-29 20:20

$Loxo Oncology, Inc. (LOXO)$ 申请上市查看全文

琳子的日复一日2018-05-19 22:52

$Loxo Oncology, Inc. (LOXO)$ 今日，致力于为基因定义的癌症患者研发高度选择性疗法的生物医药公司Loxo Oncology宣布将要在6月初召开的美国临床肿瘤学会（ASCO）年会上公布其潜力新药LOXO-292的1期临床试验的中期数据。这一题为“A Phase 1 Study of LOXO-292, A Potent and Highly Selective RET...查看全文

-P5 | 止损就像自宫，切不下去

不予置评2018-05-18 00:20

回来太晚，前期准备不够充分。盘前的一小时非常重要，不然就像今天观察的股票太多，无法专心操作。每个都想分一杯羹，却每个都做得不好。
ps:M是昨天的遗留问题，忽略不计。WWE仓促下单，又没有设置止损线，这个错误本来可以避免。今天做得相对较好的操作是NTES。LOXO的问题比较大，下面细说。...查看全文

大叶韭菜2018-05-17 23:30

$药石科技(SZ300725)$ 药石第三大客户$Loxo Oncology, Inc. (LOXO)$ 研发重磅新药 目前涨幅20% 预期利好上游企业查看全文

张小丰2018-05-17 08:45

$Loxo Oncology, Inc.(LOXO)$ 这个只有几十人的公司要超神了。。又要研发出第2款超牛逼的精准小分子靶向药。 这公司人均市值上亿啊。。。。查看全文

淘沙见金2018-05-17 05:35

$Loxo Oncology, Inc. (LOXO)$ 52% overall ORR in RET across NSCLC, PTC, and MTC brought down heavily by underperformance in MTC. Confirmed ORR of 28% (11 pending). 69% ORR in fusions. Much better compare with $Blueprint Medicines Corporation(BPMC)$ 查看全文

淘沙见金2018-04-16 10:52

$Blueprint Medicines Corporation(BPMC)$ 出产神药的称呼真不是吹的，感觉 $Loxo Oncology, Inc.(LOXO)$ 的RET 抑制剂很难这么有效。查看全文

御波者WaveRider2018-04-09 22:28

下一个估计是 $Loxo Oncology, Inc.(LOXO)$ //@御波者WaveRider:$Aves, Inc.(AVXS)$ 早就说了查看全文

琳子的日复一日2018-04-08 21:50

$Loxo Oncology, Inc.(LOXO)$
德国制药巨头拜耳（Bayer）与合作伙伴Loxo Oncology近日联合宣布，双方已完成向美国食品和药物管理局（FDA）滚动提交靶向药物larotrectinib的新药申请（NDA），希望批准larotrectinib用于存在神经营养酪氨酸激酶（NTRK）基因融合的局部晚期或转移性实体瘤儿科及...查看全文

琳子的日复一日2018-03-14 20:45

随着明星抗癌药的上市消息临近， $Loxo Oncology, Inc.(LOXO)$ 会不会继续run up？拭目以待查看全文

$Loxo Oncology(LOXO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-20-003307  Act: 34  Size: 10 KB 网页链接

$Loxo Oncology(LOXO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902219-20-000048  Act: 34  Size: 32 KB 网页链接

$Loxo Oncology(LOXO)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2019-02-25 AccNo: 0001193125-19-049296 Size: 10 KB 网页链接

$Loxo Oncology(LOXO)$ EFFECT - Notice of Effectiveness Filed: 2019-02-21 AccNo: 9999999995-19-000306 Size: 1 KB 网页链接

$Loxo Oncology(LOXO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-02-15 AccNo: 0000950142-19-000290 Size: 146 KB 网页链接

$Loxo Oncology(LOXO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-02-15 AccNo: 0001193125-19-042490 Size: 18 KB 网页链接

$Loxo Oncology(LOXO)$ POSASR - Post-effective Amendment to an automatic shelf registration statement Filed: 2019-02-15 AccNo: 0001193125-19-042498 Size: 18 KB 网页链接

$Loxo Oncology(LOXO)$ 8-K - Current report Filed: 2019-02-15 AccNo: 0001193125-19-042505 Size: 114 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem...

$Loxo Oncology(LOXO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-15 AccNo: 0001193125-19-042509 Size: 26 KB 网页链接

$Loxo Oncology(LOXO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-02-15 AccNo: 0001193125-19-042519 Size: 26 KB 网页链接